Status: retired, Primitive. Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
1457162014 | Mitozantrone 2mg/mL injection concentrate 15mL vial (product) | en | Fully specified name | Active | Initial character case insensitive | SNOMED CT core |
1477690010 | Mitozantrone 2mg/mL injection concentrate 15mL vial | en | Synonym | Active | Initial character case insensitive | SNOMED CT core |
2794711014 | Mitozantrone 2mg/mL infusion concentrate 15mL vial | en | Synonym | Active | Initial character case insensitive | SNOMED CT core |
466680018 | Mitozantrone 30mg/15mL infusion | en | Synonym | Active | Initial character case insensitive | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Mitozantrone 2mg/mL injection concentrate 15mL vial | Is a | Mitoxantrone-containing product | false | Inferred relationship | Some | ||
Mitozantrone 2mg/mL injection concentrate 15mL vial | Has active ingredient | Mitozantrone | false | Inferred relationship | Some | ||
Mitozantrone 2mg/mL injection concentrate 15mL vial | Has active ingredient | Anthracycline | false | Inferred relationship | Some | ||
Mitozantrone 2mg/mL injection concentrate 15mL vial | Has manufactured dose form | Injection | false | Inferred relationship | Some | ||
Mitozantrone 2mg/mL injection concentrate 15mL vial | Is a | Product manufactured as parenteral dose form | false | Inferred relationship | Some | ||
Mitozantrone 2mg/mL injection concentrate 15mL vial | Has manufactured dose form | Injection concentrate | false | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set